AB 2571: Reimbursement for pharmacist services.
- Session Year: 2025-2026
- House: Assembly
- Latest Version Date: 2026-09-01
Current Status:
Failed
(2026-09-27: Vetoed by Governor.)
Introduced
In Committee
Awaiting First Chamber Vote
Passed First Chamber
In Committee
Awaiting Second Chamber Vote
Passed Second Chamber
Enacted
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would additionally require the rate of reimbursement for advanced pharmacist practitioner services to be no less than 85% of the fee schedule for physician services, including MTM pharmacist services. The bill would, subject to, among other things, federal approval, require advanced pharmacist practitioners to be recognized as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible advanced pharmacist practitioners or pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by a pharmacist enrolled as a provider with the plan or insurer. The bill would specify for these purposes that a pharmacist includes pharmacists who provide services at a federally qualified health center or a rural health clinic. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would additionally require the rate of reimbursement for advanced practice pharmacist pharmacist practitioner services to be no less than 85% of the fee schedule for physician services, including MTM pharmacist services. The bill would, subject to, among other things, federal approval, require advanced pharmacist practitioners to be recognized as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible advanced practice pharmacists pharmacist practitioners or pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by a pharmacist enrolled as a provider with the plan or insurer. The bill would specify for these purposes that a pharmacist includes pharmacists who provide services at a federally qualified health center or a rural health clinic. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would additionally require the rate of reimbursement for advanced practice pharmacist services to be the same as no less than 85% of the fee schedule for physician services, including MTM pharmacist services. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by a pharmacist enrolled as a provider with the plan or insurer. The bill would specify for these purposes that a pharmacist includes pharmacists who provide services at a federally qualified health center or a rural health clinic. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would additionally require the rate of reimbursement for advanced practice pharmacist services to be the same as the fee schedule for physician services, including MTM pharmacist services. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by an advanced practice a pharmacist enrolled as a provider with the plan or insurer. The bill would specify for these purposes that a pharmacist includes pharmacists who provide services at a federally qualified health center or a rural health clinic. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
Existing law provides for the Medi-Cal program, administered by the State Department of Health Care Services and under which health care services are provided to low-income individuals pursuant to a schedule of benefits. The Medi-Cal program is, in part, governed and funded by federal Medicaid program provisions. Under existing law, pharmacist services are a benefit under the Medi-Cal program, subject to federal approval, and the rate of reimbursement for pharmacist services is 85% of the fee schedule for physician services, except for medication therapy management (MTM) pharmacist services. Existing law requires the department to implement an MTM reimbursement methodology relating to the dispensing of qualified specialty drugs by an eligible contracting pharmacy, which would be intended to supplement Medi-Cal payments to eligible pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
This bill would additionally require the rate of reimbursement for advanced practice pharmacist services to be the same as the fee schedule for physician services, including MTM pharmacist services. The bill would require the department to implement an MTM reimbursement methodology relating to the use of drugs to ensure that Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories.
Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of health insurers by the Department of Insurance. Existing law requires a health care service plan or disability insurer that offers coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. Existing law authorizes this payment or reimbursement when specified conditions are met, including that the coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
This bill would additionally require those health care service plans and disability insurers to pay or reimburse the cost of the service performed by an advanced practice pharmacist enrolled as a provider with the plan or insurer. The bill would authorize payment or reimbursement if the coverage otherwise provides reimbursement for similar services performed by other licensed health care providers, among other requirements. Because a willful violation of the bills requirements relative to health care service plans would be a crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
(a) A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit, or a pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c) This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
(e)This section does not apply to a Medi-Cal managed care plan that contracts with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000) and Chapter 8 (commencing with Section 14200) of Part 3 of Division 9 of the Welfare and Institutions Code.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit, or a pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c)This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(4)The rate of reimbursement for advanced pharmacist practitioner services shall be no less than 85 percent of the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(e)(1)Subject to paragraph (2), advanced pharmacist practitioners shall be recognized as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program.
(2)The department shall seek federal approval of a state plan amendment to implement paragraph (1). Paragraph (1) shall be implemented only to the extent that this federal approval and any other necessary federal approvals have been obtained, that federal financial participation is available, and subject to an appropriation made by the Legislature in the annual Budget Act or another statute.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs. MTM reimbursement pursuant to this section is intended to ensure Medi-Cal payments are only made to eligible advanced pharmacist practitioners or pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible advanced pharmacist practitioner that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a) A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit, or a pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c) This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
(e)This section does not apply to a Medi-Cal managed care plan that contracts with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000) and Chapter 8 (commencing with Section 14200) of Part 3 of Division 9 of the Welfare and Institutions Code.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit, or a pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c)This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(4)The rate of reimbursement for advanced practice pharmacist pharmacist practitioner services shall be no less than 85 percent of the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(e)The department shall seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program.(e)(1)Subject to paragraph (2), advanced pharmacist practitioners shall be recognized as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program.
(2)The department shall seek federal approval of a state plan amendment to implement paragraph (1). Paragraph (1) shall be implemented only to the extent that this federal approval and any other necessary federal approvals have been obtained, that federal financial participation is available, and subject to an appropriation made by the Legislature in the annual Budget Act or another statute.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs. MTM reimbursement pursuant to this section is intended to ensure Medi-Cal payments are only made to eligible advanced practice pharmacists pharmacist practitioners or pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible advanced practice pharmacist pharmacist practitioner that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a) A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit, or a pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c) This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
(e)This section does not apply to a Medi-Cal managed care plan that contracts with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000) and Chapter 8 (commencing with Section 14200) of Part 3 of Division 9 of the Welfare and Institutions Code.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit, or a pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c)This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(4)The rate of reimbursement for advanced practice pharmacist services shall be the same as no less than 85 percent of the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(e)The department shall seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs. MTM reimbursement pursuant to this section is intended to ensure Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible advanced practice pharmacist that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a) A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit, or an advanced practice a pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c) This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit, or an advanced practice a pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for similar services performed by other licensed health care providers.
(c)This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
(d)For purposes of this section, pharmacist includes a pharmacist providing services at a federally qualified health center or a rural health clinic, as those terms are defined in Section 1396d(l) of Title 42 of the United States Code.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(4)The rate of reimbursement for advanced practice pharmacist services shall be the same as the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(e)The department shall seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs. MTM reimbursement pursuant to this section is intended to ensure Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies pharmacies, including those operating at federally qualified health centers or rural health clinics, for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible advanced practice pharmacist that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section does not restrict or prohibit services currently provided by pharmacists as authorized by law, including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
(a) Every A health care service plan that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or pharmacy, a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit. benefit, or an advanced practice pharmacist enrolled as a provider with the health care service plan.
(b) Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1) The service performed is within the lawful scope of practice of the pharmacist.
(2) The coverage otherwise provides reimbursement for identical similar services performed by other licensed health care providers.
(c) Nothing in this section shall This section does not require the plan to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
SEC. 2.Section 10125.1 of the Insurance Code is amended to read:10125.1.(a)Every An insurer issuing disability insurance that covers hospital, medical, or surgical expenses that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist shall pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or pharmacy, a pharmacist at an out-of-network pharmacy if the insurer has an out-of-network pharmacy benefit. benefit, or an advanced practice pharmacist enrolled as a provider with the insurer.
(b)Payment or reimbursement may be made pursuant to this section for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
(1)The service performed is within the lawful scope of practice of the pharmacist.
(2)The coverage otherwise provides reimbursement for identical similar services performed by other licensed health care providers.
(c)Nothing in this section shall This section does not require the insurer to pay a claim to more than one provider for duplicate service or be interpreted to limit physician reimbursement.
SEC. 3.Section 14132.968 of the Welfare and Institutions Code is amended to read:14132.968.(a)(1)Pharmacist services are a benefit under the Medi-Cal program, subject to approval by the federal Centers for Medicare and Medicaid Services.
(2)The department shall establish a fee schedule for the list of pharmacist services.
(3)The rate of reimbursement for pharmacist services shall be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for medication therapy management (MTM) pharmacist services as described in Section 14132.969.
(4)The rate of reimbursement for advanced practice pharmacist services shall be the same as the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services as described in Section 14132.969.
(b)(1)The following services are covered pharmacist services that may be provided to a Medi-Cal beneficiary:
(A)Furnishing travel medications, as authorized in clause (3) of subparagraph (A) of paragraph (10) of subdivision (a) of Section 4052 of the Business and Professions Code.
(B)Furnishing naloxone hydrochloride, as authorized in Section 4052.01 of the Business and Professions Code.
(C)Furnishing self-administered hormonal contraception, as authorized in subdivision (a) of Section 4052.3 of the Business and Professions Code.
(D)Initiating and administering immunizations, as authorized in Section 4052.8 of the Business and Professions Code.
(E)Providing tobacco cessation counseling and furnishing nicotine replacement therapy, as authorized in Section 4052.9 of the Business and Professions Code.
(F)Initiating and furnishing preexposure prophylaxis, as authorized in Section 4052.02 of the Business and Professions Code.
(G)Initiating and furnishing postexposure prophylaxis, as authorized in Section 4052.03 of the Business and Professions Code.
(H)Providing MTM pharmacist services in conjunction with the dispensing use of qualified specialty drugs, as described in Section 14132.969.
(2)Covered pharmacist services shall be subject to department protocols and utilization controls.
(c)A pharmacist shall be enrolled as an ordering, referring, and prescribing provider under the Medi-Cal program prior to before rendering a pharmacist service that is submitted by a pharmacist or a Medi-Cal pharmacy provider for reimbursement pursuant to this section.
(d)(1)The director shall seek any necessary federal approvals to implement this section. This section shall not be implemented until the necessary federal approvals are obtained and shall be implemented only to the extent that federal financial participation is available.
(2)This section neither restricts nor prohibits any does not restrict or prohibit services currently provided by pharmacists as authorized by law, including, but not limited to, this chapter, or including this chapter and the Medicaid state plan.
(e)The department shall seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers for reimbursement purposes under the Medi-Cal program.
(e)(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, and any applicable federal waivers and state plan amendments, by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action. By July 1, 2021, the department shall adopt regulations in accordance with the requirements of Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code. Commencing July 1, 2017, the department shall provide a status report to the Legislature on a semiannual basis, in compliance with Section 9795 of the Government Code, until regulations have been adopted.
SEC. 4.Section 14132.969 of the Welfare and Institutions Code is amended to read:14132.969.(a)Subject to an annual appropriation for this express purpose, the department shall implement a medication therapy management (MTM) reimbursement methodology for covered pharmacist services related to the dispensing use of qualified specialty drugs by an eligible pharmacy contracted with the department pursuant to subdivision (c). drugs. MTM reimbursement pursuant to this section is intended to supplement ensure Medi-Cal payments are only made to eligible advanced practice pharmacists or pharmacies for MTM pharmacist services provided in conjunction with certain specialty drug therapy categories, as identified by the department pursuant to paragraph (2) of subdivision (b).
(b)In implementing this section, the department shall do all of the following:
(1)Establish and maintain protocols and utilization controls for covered MTM pharmacist services.
(2)Establish and maintain a list of covered specialty drug therapy categories for which MTM pharmacist services reimbursement is available.
(3)Establish and maintain rates of reimbursement for covered MTM pharmacist services under contracts with participating pharmacies pursuant to subdivision (c).
(4)Establish and maintain the eligibility criteria and conditions for receipt of MTM pharmacist services reimbursement pursuant to this section.
(c)(1)MTM pharmacist services reimbursement pursuant to this section shall only be available to a Medi-Cal enrolled pharmacy or an eligible advanced practice pharmacist that enters into an MTM pharmacist services contract with the department.
(2)For purposes of implementing this section, the department may enter into exclusive or nonexclusive contracts, or amend existing contracts, on a bid or negotiated basis. Contracts entered into or amended pursuant to this subdivision shall be exempt from Chapter 6 (commencing with Section 14825) of Part 5.5 of Division 3 of Title 2 of the Government Code, Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code, and the State Administrative Manual, and shall be exempt from the review or approval of any division of the Department of General Services.
(d)(1)This section shall apply to dates of service on or after July 1, 2021, or to dates of service on or after the effective date reflected in any necessary federal approvals obtained by the department pursuant to paragraph (2), whichever is later.
(2)The department shall seek any necessary federal approvals to implement this section.
(3)This section shall be implemented only to the extent that any necessary federal approvals are obtained and federal financial participation is available and is not otherwise jeopardized.
(e)This section neither restricts nor prohibits any does not restrict or prohibit services currently provided by pharmacists as authorized by law, including, but not limited to, this chapter, or including this chapter and the Medicaid state plan.
(f)Notwithstanding Chapter 3.5 (commencing with Section 11340) of Part 1 of Division 3 of Title 2 of the Government Code, the department may implement, interpret, or make specific this section, in whole or in part, by means of provider bulletins or other similar instructions, without taking any further regulatory action.
(g)For purposes of this section, the following definitions apply:
(1)Medication therapy management or MTM means a distinct service or group of services, as determined by the department, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes.
(2)Specialty drugs has the same meaning as set forth in paragraph (13) of subdivision (a) of Section 14105.45.
SEC. 5.No reimbursement is required by this act pursuant to Section 6 of Article XIIIB of the California Constitution because the only costs that may be incurred by a local agency or school district will be incurred because this act creates a new crime or infraction, eliminates a crime or infraction, or changes the penalty for a crime or infraction, within the meaning of Section 17556 of the Government Code, or changes the definition of a crime within the meaning of Section 6 of Article XIIIB of the California Constitution.
|
Date
|
Status
|
|---|---|
| Sep 27, 2026 | Vetoed by Governor. |
| Sep 4, 2026 | Enrolled and presented to the Governor at 4 p.m. |
| Aug 27, 2026 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0. Page 6678.). |
| Aug 27, 2026 | Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 78. Noes 0.). |
| Aug 25, 2026 | In Assembly. Concurrence in Senate amendments pending. |
| Aug 25, 2026 | Read third time. Passed. Ordered to the Assembly. (Ayes 40. Noes 0. Page 5779.). |
| Aug 25, 2026 | Read third time. Passed. Ordered to the Assembly. (Ayes 39. Noes 0.). |
| Aug 24, 2026 | Read second time. Ordered to third reading. |
| Aug 20, 2026 | Read third time and amended. Ordered to second reading. |
| Aug 19, 2026 | Ordered to third reading. |
| Aug 19, 2026 | From special consent calendar. |
| Aug 18, 2026 | Ordered to special consent calendar. |
| Aug 13, 2026 | Read second time. Ordered to third reading. |
| Aug 13, 2026 | From committee: Do pass. (Ayes 7. Noes 0.) (August 13). |
| Jun 15, 2026 | In committee: Referred to APPR. suspense file. |
| Jun 15, 2026 | In committee: Referred to suspense file. |
| Jun 8, 2026 | Read second time and amended. Re-referred to Com. on APPR. |
| Jun 4, 2026 | From committee: Amend, and do pass as amended and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 9. Noes 0.) (June 3). |
| May 20, 2026 | From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. |
| May 6, 2026 | Referred to Com. on HEALTH. |
| Apr 16, 2026 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Apr 16, 2026 | Read third time. Passed. Ordered to the Senate. (Ayes 68. Noes 0. Page 4683.) |
| Apr 16, 2026 | Read third time. Passed. Ordered to the Senate. (Ayes 68. Noes 0.) |
| Apr 9, 2026 | Read second time. Ordered to Consent Calendar. |
| Apr 8, 2026 | From committee: Do pass. To Consent Calendar. (Ayes 14. Noes 0.) (April 8). |
| Mar 25, 2026 | From committee: Do pass and re-refer to Com. on APPR. with recommendation: To Consent Calendar. (Ayes 16. Noes 0.) (March 24). Re-referred to Com. on APPR. |
| Mar 9, 2026 | Referred to Com. on HEALTH. |
| Feb 21, 2026 | From printer. May be heard in committee March 23. |
| Feb 20, 2026 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Aug 27, 2026 | AB 2571 Flora Concurrence in Senate Amendments | Assembly Floor |
Passed |
|
| Aug 25, 2026 | Assembly 3rd Reading AB2571 Flora By Ashby | Senate Floor |
Passed |
|
| Aug 13, 2026 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 15, 2026 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 3, 2026 | Do pass as amended, but first amend, and re-refer to the Committee on [Appropriations] with the recommendation: To Consent Calendar | Senate Standing Committee on Health |
Passed |
|
| Apr 16, 2026 | AB 2571 Flora Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Apr 8, 2026 | Do pass. To Consent Calendar. | Assembly Standing Committee on Appropriations |
Passed |
|
| Mar 24, 2026 | Do pass and be re-referred to the Committee on [Appropriations] with recommendation: To Consent Calendar | Assembly Standing Committee on Health |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| American Society of Health-System Pharmacists | ** Support | |
| America’s Physician Groups | ** Support | |
| California Academy Of Family Physicians | ** Support | |
| California Access Coalition | ** Support | |
| California Medical Association | ** Support | |
| California Pharmacists Association | ** Support | |
| CALIFORNIA PRIMARY CARE ASSOCIATION ADVOCATES | ** Support | |
| California Society Of Health-System Pharmacists | ** Support | |
| California Society of Health-System Pharmacists (source) | ** Support | |
| California State Board of Pharmacy | ** Support | |
| City and County of San Francisco | ** Support | |
| County of Kern, Supervisor Chris Parlier | ** Support | |
| Keck Medicine of the University of Southern California | ** Support | |
| National Hispanic Pharmacists Association | ** Support | |
| Stanford Medicine Children's Health | ** Support | |
| The California Society of Health-System Pharmacists (CSHP) | ** Support | |
| TrueCare | ** Support |
GOVERNOR'S VETO
GV Bill Id:AB 2571
Author:(Flora)
As Enrolled Ver:September 1, 2026
2/3 vote
SUMMARY
Requires advanced pharmacist practitioners (APPs) enrolled as providers with a health care service plan (health plan), health insurer, or the Medi-Cal program to be reimbursed for medication therapy management (MTM) services.
Senate Amendments
- Alter provisions requiring APPs to be recognized as health care providers at federally qualified health centers (FQHCs) and rural health clinics (RHCs) for reimbursement under the Medi-Cal program to be contingent on the Department of Health Care Services (DHCS) seeking federal approval of a state plan amendment. Subjects DHCS' seeking of federal approval upon appropriation by the State.
- Reduce Medi-Cal payment requirement for APP services from the same as the fee schedule physician services to no less than 85% of the fee schedule for physician services.
- Clarify that the payment provisions under this bill also apply to pharmacists providing services at FQHCs and RHCs.
Governor's Veto Message
I appreciate the author's intent to improve access to advanced pharmacist services for Medi-Cal members, especially for those seeking care at FQHCs or RHCs. However, this bill would result in millions of dollars in ongoing, annual costs related to FQHC reimbursement, as well as millions in one-time costs to implement the required system changes, neither of which were accounted for in this year's budget.
In partnership with the Legislature this year, my administration enacted a balanced budget that recognizes the challenging fiscal landscape our state faces while maintaining our commitment to working families and our most vulnerable communities. With significant fiscal pressures and the federal government's hostile economic policies, it is vital that we remain disciplined when considering bills with significant fiscal implications that are not included in the budget, such as this measure.
COMMENTS
MTM is a strategy to improve health outcomes and detect and prevent costly medication problems. MTM services aim to improve medication adherence, reduce adverse drug events, prevent hospitalizations, and produce measurable cost savings. Numerous studies provided by the author's office offer evidence that MTM programs can reduce total healthcare spending by optimizing therapeutic outcomes, eliminating unnecessary or duplicative medication use, and improving management of chronic conditions such as diabetes, hypertension, and asthma. Current law authorizes pharmacists to be reimbursed for MTM services; however, those services must be provided within or affiliated with a pharmacy. Individual pharmacists, such as those employed in hospitals, FQHCs, rural health clinics, mobile clinics, academic medical centers, and physician practices, are not permitted to bill for these services without affiliation at a pharmacy. This discrepancy in reimbursement structure is impactful as brick-and-mortar pharmacies are rapidly declining across the state. According to research published by the UC Berkeley School of Public Health and the University of Southern California, 1 in 3 pharmacies have closed since 2010 and thousands more closures are expected in the coming years. These closures have created pharmacy deserts that not only impact patient access to prescriptions, but also pharmacist-provided services such as MTM due to reimbursement limitations.
APPs. Existing law authorizes pharmacists to furnish compounded drug products, transmit a valid prescription to another pharmacist, and administer drugs and biologicals pursuant to a prescriber's order. SB 493 (Hernandez), Chapter 469, Statutes of 2013, expands the scope of pharmacists to authorize them to furnish self-administered hormonal contraceptives, vaccines, nicotine replacement products, and travel medications. Additionally, SB 493 authorizes the Board of Pharmacy (BOP) to recognize APPs who can perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy.
Reimbursement to Pharmacists Would be New for Medi-Cal. Medi-Cal covers pharmacist services; however, these services are reimbursed to contracting pharmacies, not directly to pharmacists. For pharmacists to receive reimbursement directly, DHCS would likely have to create an enrollment pathway, and pharmacists would have to newly enroll as billing providers. Pharmacists are also similarly not recognized as "reimbursable" providers within an FQHC or RHC if services are provided outside of a pharmacy [see 6) of Existing Law in the Assembly Health Committee policy analysis for the list of recognized providers within an FQHC or RHC setting]. Enrolling and reimbursing advance practice pharmacists directly could improve access to services provided by these pharmacists, such as MTM, and could increase the flexibility of how pharmacists may be used as part of care teams within health care systems.
According to the Author
According to the author, MTM is a proven, cost-effective service that improves patient outcomes, reduces healthcare spending, and addresses chronic disease management gaps—particularly in underserved communities. The author states that pharmacists are uniquely qualified medication experts who help patients manage complex drug regimens, identify harmful interactions, and increase adherence to prescribed treatments. The author continues that these services, whether provided in a community pharmacy, clinic, hospital, or via telehealth, directly reduce emergency room visits, hospitalizations, and avoidable complications. The author argues that limiting reimbursement to services performed within a brick-and-mortar pharmacy ignores the evolving realities of healthcare delivery, especially in the face of widespread pharmacy closures and the expansion of mobile and remote care models. The author concludes that paying pharmacists for MTM regardless of location not only aligns with modern healthcare infrastructure but also ensures equitable access to life-saving services for the Medi-Cal patients who need them most.
Arguments in Support
The California Society of Health-System Pharmacists (CSHP), sponsors of this bill, state that under current law, pharmacists' MTM services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy, despite the fact that pharmacists increasingly practice in clinics, hospitals, physician group practices, mobile health units, and other community-based settings. CSHP continues that this outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures accelerate in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. CSHP argues that this bill addresses this gap by allowing Medi-Cal and health plans to reimburse individual pharmacists enrolled as providers for MTM services regardless of whether those services are delivered in a traditional pharmacy or in another clinical setting. CSHP concludes that by recognizing pharmacists as reimbursable providers in a wider range of settings, this bill will expand access to preventive and chronic care services, improve continuity of care, and advance health equity for patients living in "pharmacy deserts" and other medically underserved communities.
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Senate Appropriations Committee, unknown ongoing costs, potentially hundreds of thousands, for DHCS for state administration and unknown cost pressures in the Medi-Cal program related to reimbursements for pharmacist services (General Fund and federal funds). The Department of Managed Health Care anticipates minor and absorbable costs for state administration. The California Department of Insurance estimates costs of $3,000 in 2026-27 and $16,000 in 2027-28 for state administration (Insurance Fund).
VOTES
ASM HEALTH: 16-0-0
YES: Bonta, Chen, Addis, Aguiar-Curry, Pacheco, Caloza, Carrillo, Mark González, Johnson, Patel, Patterson, Rogers, Sanchez, Schiavo, Sharp-Collins, Stefani
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Hoover, Arambula, Caloza, Dixon, Fong, Mark González, Krell, Muratsuchi, Pacheco, Pellerin, Solache, Ta, Tangipa
ABS, ABST OR NV: Calderon
ASSEMBLY FLOOR: 68-0-12
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Boerner, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
ABS, ABST OR NV: Arambula, Berman, Bonta, Dixon, Flora, Harabedian, Hart, Hoover, Irwin, Papan, Celeste Rodriguez, Schiavo
SENATE FLOOR: 40-0-0
YES: Allen, Alvarado-Gil, Archuleta, Arreguín, Ashby, Becker, Blakespear, Cabaldon, Caballero, Cervantes, Choi, Cortese, Dahle, Durazo, Gonzalez, Grayson, Grove, Hurtado, Jones, Laird, Limón, McGuire, McNerney, Menjivar, Niello, Ochoa Bogh, Padilla, Pérez, Reyes, Richardson, Rubio, Seyarto, Smallwood-Cuevas, Stern, Strickland, Umberg, Valladares, Wahab, Weber Pierson, Wiener
ASSEMBLY FLOOR: 78-0-1
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Arambula, Ávila Farías, Bains, Bauer-Kahan, Bennett, Berman, Boerner, Bonta, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Dixon, Elhawary, Ellis, Flora, Fong, Gabriel, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Harabedian, Hart, Hoover, Irwin, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, Muratsuchi, Nguyen, Ortega, Pacheco, Papan, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Celeste Rodriguez, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schiavo, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
ABS, ABST OR NV: McKinnor
UPDATED
VERSION: September 1, 2026
CONSULTANT: Riana King / HEALTH / (916) 319-2097 FN: 0004642
CONCURRENCE IN SENATE AMENDMENTS
CSA1 Bill Id:AB 2571
Author:(Flora)
As Amended Ver:August 20, 2026
Majority vote
SUMMARY
Requires advanced pharmacist practitioners (APPs) enrolled as providers with a health care service plan (health plan), health insurer, or the Medi-Cal program to be reimbursed for medication therapy management (MTM) services.
Senate Amendments
- Alter provisions requiring APPs to be recognized as health care providers at federally qualified health centers (FQHCs) and rural health clinics (RHCs) for reimbursement under the Medi-Cal program to be contingent on the Department of Health Care Services (DHCS) seeking federal approval of a state plan amendment. Subjects DHCS' seeking of federal approval upon appropriation by the State.
- Reduce Medi-Cal payment requirement for APP services from the same as the fee schedule physician services to no less than 85% of the fee schedule for physician services.
- Clarify that the payment provisions under this bill also apply to pharmacists providing services at FQHCs and RHCs.
COMMENTS
MTM is a strategy to improve health outcomes and detect and prevent costly medication problems. MTM services aim to improve medication adherence, reduce adverse drug events, prevent hospitalizations, and produce measurable cost savings. Numerous studies provided by the author’s office offer evidence that MTM programs can reduce total healthcare spending by optimizing therapeutic outcomes, eliminating unnecessary or duplicative medication use, and improving management of chronic conditions such as diabetes, hypertension, and asthma. Current law authorizes pharmacists to be reimbursed for MTM services; however, those services must be provided within or affiliated with a pharmacy. Individual pharmacists, such as those employed in hospitals, FQHCs, rural health clinics, mobile clinics, academic medical centers, and physician practices, are not permitted to bill for these services without affiliation at a pharmacy. This discrepancy in reimbursement structure is impactful as brick-and-mortar pharmacies are rapidly declining across the state. According to research published by the UC Berkeley School of Public Health and the University of Southern California, 1 in 3 pharmacies have closed since 2010 and thousands more closures are expected in the coming years. These closures have created pharmacy deserts that not only impact patient access to prescriptions, but also pharmacist-provided services such as MTM due to reimbursement limitations.
APPs. Existing law authorizes pharmacists to furnish compounded drug products, transmit a valid prescription to another pharmacist, and administer drugs and biologicals pursuant to a prescriber's order. SB 493 (Hernandez), Chapter 469, Statutes of 2013, expands the scope of pharmacists to authorize them to furnish self-administered hormonal contraceptives, vaccines, nicotine replacement products, and travel medications. Additionally, SB 493 authorizes the Board of Pharmacy (BOP) to recognize APPs who can perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy.
Reimbursement to Pharmacists Would be New for Medi-Cal. Medi-Cal covers pharmacist services; however, these services are reimbursed to contracting pharmacies, not directly to pharmacists. For pharmacists to receive reimbursement directly, DHCS would likely have to create an enrollment pathway, and pharmacists would have to newly enroll as billing providers. Pharmacists are also similarly not recognized as “reimbursable” providers within an FQHC or RHC if services are provided outside of a pharmacy [see 6) of Existing Law in the Assembly Health Committee policy analysis for the list of recognized providers within an FQHC or RHC setting]. Enrolling and reimbursing advance practice pharmacists directly could improve access to services provided by these pharmacists, such as MTM, and could increase the flexibility of how pharmacists may be used as part of care teams within health care systems.
According to the Author
According to the author, MTM is a proven, cost-effective service that improves patient outcomes, reduces healthcare spending, and addresses chronic disease management gaps—particularly in underserved communities. The author states that pharmacists are uniquely qualified medication experts who help patients manage complex drug regimens, identify harmful interactions, and increase adherence to prescribed treatments. The author continues that these services, whether provided in a community pharmacy, clinic, hospital, or via telehealth, directly reduce emergency room visits, hospitalizations, and avoidable complications. The author argues that limiting reimbursement to services performed within a brick-and-mortar pharmacy ignores the evolving realities of healthcare delivery, especially in the face of widespread pharmacy closures and the expansion of mobile and remote care models. The author concludes that paying pharmacists for MTM regardless of location not only aligns with modern healthcare infrastructure but also ensures equitable access to life-saving services for the Medi-Cal patients who need them most.
Arguments in Support
The California Society of Health-System Pharmacists (CSHP), sponsors of this bill, state that under current law, pharmacists’ MTM services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy, despite the fact that pharmacists increasingly practice in clinics, hospitals, physician group practices, mobile health units, and other community-based settings. CSHP continues that this outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures accelerate in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. CSHP argues that this bill addresses this gap by allowing Medi-Cal and health plans to reimburse individual pharmacists enrolled as providers for MTM services regardless of whether those services are delivered in a traditional pharmacy or in another clinical setting. CSHP concludes that by recognizing pharmacists as reimbursable providers in a wider range of settings, this bill will expand access to preventive and chronic care services, improve continuity of care, and advance health equity for patients living in "pharmacy deserts" and other medically underserved communities.
Arguments in Opposition
None on file.
FISCAL COMMENTS
According to the Senate Appropriations Committee, unknown ongoing costs, potentially hundreds of thousands, for DHCS for state administration and unknown cost pressures in the Medi-Cal program related to reimbursements for pharmacist services (General Fund and federal funds). The Department of Managed Health Care anticipates minor and absorbable costs for state administration. The California Department of Insurance estimates costs of $3,000 in 2026-27 and $16,000 in 2027-28 for state administration (Insurance Fund).
VOTES:
ASM HEALTH: 16-0-0
YES: Bonta, Chen, Addis, Aguiar-Curry, Pacheco, Caloza, Carrillo, Mark González, Johnson, Patel, Patterson, Rogers, Sanchez, Schiavo, Sharp-Collins, Stefani
ASM APPROPRIATIONS: 14-0-1
YES: Wicks, Hoover, Arambula, Caloza, Dixon, Fong, Mark González, Krell, Muratsuchi, Pacheco, Pellerin, Solache, Ta, Tangipa
ABS, ABST OR NV: Calderon
ASSEMBLY FLOOR: 68-0-12
YES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Boerner, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
ABS, ABST OR NV: Arambula, Berman, Bonta, Dixon, Flora, Harabedian, Hart, Hoover, Irwin, Papan, Celeste Rodriguez, Schiavo
UPDATED
VERSION: August 20, 2026
CONSULTANT: Riana King / HEALTH / (916) 319-2097 FN: 0004104
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-4171 | AB 2571 |
THIRD READING
Bill No: AB 2571
Author: Flora (R)
Amended: 8/20/26 in Senate
Vote: 21
SENATE HEALTH COMMITTEE: 9-0, 6/3/26
AYES: Weber Pierson, Valladares, Caballero, Durazo, Gonzalez, Grove, Menjivar, Padilla, Pérez
NO VOTE RECORDED: Rubio, Smallwood-Cuevas
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/13/26
AYES: Cervantes, Seyarto, Cabaldon, Dahle, Grayson, Richardson, Wahab
ASSEMBLY FLOOR: 68-0, 4/16/26 (Consent) - See last page for vote
SUBJECT: Reimbursement for pharmacist services
SOURCE: California Society of Health-System Pharmacists
DIGEST:
This bill (1) requires a health plan or health insurer to pay or reimburse the cost of covered services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer; and (2) requires the Department of Health Care Services to reimburse enrolled Medi-Cal pharmacists for pharmacy services, reimburse enrolled advanced practice pharmacists for medication therapy management services, reimburse advanced practice pharmacists at the same rate as physicians, and submit a state plan amendment to recognize pharmacists as providers at federally qualified health centers and rural health clinics.
Senate Floor Amendments of 8/20/26:
- Change the term “advanced practice pharmacists” to “advanced pharmacist practitioners” for consistency with existing law governing advanced practice pharmacists.
- Limit the requirement to recognize pharmacists as health care providers at federally qualified health centers and rural health clinics for purposes of reimbursement in the Medi-Cal program to just advanced practice pharmacists. Conditions the implementation of this provision upon the receipt of any necessary federal approvals, federal financial participation, and an appropriation by the Legislature in the annual Budget Act or another statute.
ANALYSIS:
Existing law:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Service Plan Act of 1975 (Knox-Keene Act); California Department of Insurance (CDI) to regulate health and other insurance; and, the Department of Health Care Services (DHCS) to administer the Medi-Cal program. [Health and Safety Code [HSC] §1340, et seq., Insurance Code [INS] §106, et seq., and Welfare and Institutions Code [WIC] §14000, et seq.]
- Requires a health plan or health insurer covering hospital, medical, or surgical expenses, that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the health plan or health insurance has an out-of-network pharmacy benefit. [HSC §1368.5 and INS §10125.1]
- Requires payment or reimbursement described in 2) above to be made for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
- The service performed is within the lawful scope of practice of the pharmacist;
- The coverage otherwise provides reimbursement for identical services performed by other licensed health care providers; and,
- This does not require the plan or insurer to pay a claim to more than one provider for duplicate service or limit physician reimbursement. [HSC §1368.5 and INS §10125.1]
- Establishes pharmacist services as a Medi-Cal benefit, subject to federal approval, DHCS protocols, and utilization controls. [WIC §14132.968]
- Sets the reimbursement rate for pharmacist services, except for medication therapy management, at 85% of the fee schedule for physician services. [WIC §14132.968]
- Requires DHCS, subject to an annual appropriation for this express purpose, to implement a medication therapy management reimbursement methodology for covered pharmacist services related to the dispensing of qualified specialty drugs by an eligible pharmacy contracted with DHCS. Defines “medication therapy management” as a distinct service or group of services, as determined by DHCS, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes. [WIC §14132.969]
- Defines, for purposes of reimbursement to federally qualified health centers and rural health clinics, a “visit” as a face-to-face encounter between a health center or clinic patient and a physician, physician assistant, nurse practitioner, certified nurse-midwife, clinical psychologist, licensed clinical social worker, licensed professional clinical counselor, or a visiting nurse. A visit also includes a face-to-face encounter between a health center or clinic patient and a comprehensive perinatal practitioner providing comprehensive perinatal services, a four-hour day of attendance at an adult day health care center, and any other provider identified in the state plan’s definition of a federally qualified health center or rural health clinic visit. [WIC §14132.100]
- Establishes licensure for an advanced practice pharmacist, and requires the person to meet all of the following:
- Hold an active license to practice pharmacy issued that is in good standing; and,
- Satisfy any two of the following criteria:
- Earn certification in a relevant area of practice, including, but not limited to, ambulatory care, critical care, geriatric pharmacy, nuclear pharmacy, nutrition support pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, or psychiatric pharmacy, from an organization recognized by the Accreditation Council for Pharmacy Education or another entity recognized by California Board of Pharmacy;
- Complete a postgraduate residency through an accredited postgraduate institution where at least 50% of the experience includes the provision of direct patient care services with interdisciplinary teams; or,
- Have provided clinical services to patients for at least one year under a collaborative practice agreement or protocol with a physician, advanced practice pharmacist, pharmacist practicing collaborative drug therapy management, or health system. [Business and Professions Code (BPC) §4210]
- Allows a pharmacist recognized by the Board of Pharmacy as an advanced practice pharmacist to do all of the following:
- Perform patient assessments;
- Order and interpret drug therapy-related tests;
- Refer patients to other health care providers;
- Participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers; and,
- Initiate, adjust, or discontinue drug therapy, as specified. [BPC §4052.6]
This bill:
- Requires a health plan or health insurer, except for Medi-Cal plans, to pay or reimburse the cost of services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer, and the service is similar, rather than identical, to those performed by other licensed providers. Specifies that pharmacists providing services at federally qualified health centers or rural health clinics are included as pharmacists.
- Requires DHCS to reimburse advanced practice pharmacist services no less than 85% of the fee schedule for physician services under the Medi-Cal program, including for medication therapy management.
- Authorizes pharmacists to submit for Medi-Cal reimbursement for pharmacist services, rather than just a pharmacy, so long as the pharmacist is an enrolled Medi-Cal provider before providing the service.
- Authorizes enrolled advanced practice pharmacists, in addition to enrolled Medi-Cal pharmacies, to submit for Medi-Cal reimbursement for medication therapy management services, including those operating at federally qualified health centers or rural health clinics.
- Requires DHCS to seek federal approval of a state plan amendment to recognize advanced practice pharmacists as providers at federally qualified health centers and rural health clinics for Medi-Cal reimbursement and conditions. Implements the recognition of advanced practice pharmacists as providers at these health centers and clinics upon the availability of federal financial participation and an appropriation made by the Legislature.
Background
According to the author of this bill:
This bill strengthens pharmacists’ role as healthcare providers through expanded reimbursement and integration into Medi-Cal and insurance frameworks. It strengthens the case for pharmacies to operate in underserved areas and improves equitable access to basic and preventive care. Expanding reimbursement options also enables pharmacists to provide services more effectively, reducing hospitalizations, mitigating chronic conditions and improving overall health. This bill makes it viable for pharmacists to continue their work in areas where a brick-and-mortar pharmacy does not exist and promotes equity and continuity of care.
Medication therapy management. The Medi-Cal program has a specific medication therapy management program for Medi-Cal recipients with complex medication therapies, high prescription costs or other risk factors that may result in poor medication adherence as defined by DHCS. Medi-Cal recipients are eligible for these services if they are not in an inpatient or institutional setting, not eligible for Medicare Part D (this service is already covered by Part D plans), are prescribed and are currently taking a qualified specialty drug for a specified chronic or complex disease, are taking five or more chronic medications or have a single medication that Medi-Cal pays more than $75,000 for, are prescribed, and meet one of nine specified categories indicating risks of treatment failure. Eligible recipients must agree to participate in medication therapy management and can opt out at any time. Recipients eligible for the services can have six one-hour encounters per year without prior authorization; more with medical justification.
While state statute and regulations do not specifically refer to medication therapy management in the commercial market for health plans and insurance, coverage of such a service is not precluded. However, state law currently limits coverage of services provided by a pharmacist to those services provided in a pharmacy. This bill allows pharmacists enrolled with the plan or insurer, rather than just pharmacies, to bill for the benefit, thus enabling pharmacists working in patient care settings to bill. If the plan or insurer covers the service, they must reimburse the contracted pharmacist billing for the service.
Pharmacist health services. In addition to the medication management services, pharmacists in California are authorized to initiate and furnish specified health services. SB 493 (Hernandez, Chapter 469, Statutes of 2013) expanded the scope of practice of a pharmacist to permit pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, as specified, and authorized pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions. According to the Board of Pharmacy, under existing California law and regulation, qualified pharmacists are authorized to initiate and furnish the health services listed below to patients without a prescription:
- Self-administered hormonal contraception;
- Emergency contraception;
- Vaccinations;
- Travel medications;
- Nicotine replacement therapy;
- Naloxone; and,
- HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP).
Advanced practice pharmacists. SB 493 also created in statute a recognized category known as an advanced practice pharmacist (or “advanced pharmacist practitioner”). An advanced practice pharmacist must hold an active license to practice pharmacy in good standing and have additional certification, postgraduate study, and experience in providing clinical services under a collaborative practice agreement. A pharmacist recognized by the Board as an advanced practice pharmacist is authorized to perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy pursuant to a specific written order or authorization made by the individual’s treating prescriber, and in accordance with the policies, procedures or protocols of the health care facility, home health agency, licensed clinic, health plan or physician. According to the Board of Pharmacy, there are currently 1,433 advanced practice pharmacists. The Medi-Cal provisions of this bill limits pharmacist reimbursement for medication therapy management services to advanced practice pharmacists when billing outside of a pharmacy setting.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee:
- Unknown ongoing costs, potentially hundreds of thousands, for DHCS for state administration and unknown cost pressures in the Medi-Cal program related to reimbursements for pharmacist services (General Fund and federal funds).
- DMHC anticipates minor and absorbable costs for state administration.
- CDI estimates costs of $3,000 in 2026-27 and $16,000 in 2027-28 for state administration (Insurance Fund).
SUPPORT: (Verified 8/20/26)
California Society of Health-System Pharmacists (source)
America’s Physician Groups
American Society of Health-System Pharmacists
California Academy of Family Physicians
California Access Coalition
California Medical Association
California Pharmacists Association
California Primary Care Association Advocates
California State Board of Pharmacy
City and County of San Francisco
County of Kern, Supervisor Chris Parlier
Keck Medicine of the University of Southern California
National Hispanic Pharmacists Association
Stanford Medicine Children's Health
TrueCare
OPPOSITION: (Verified 8/20/26)
None received
ARGUMENTS IN SUPPORT: The source of this bill, the California Society of Health-System Pharmacists, writes that under current law, pharmacists’ medication therapy management services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy. This outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures have created pharmacy deserts in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. This bill will enable pharmacists embedded in clinics, hospitals, and telehealth programs to provide comprehensive medication reviews, titrate therapies under collaborative practice agreements, and manage chronic conditions such as diabetes, hypertension, and asthma. They state that medication therapy services have consistently demonstrated improvements in medication adherence, reductions in avoidable hospitalizations and emergency department visits, and overall decreases in health care spending, particularly for high-need Medi-Cal enrollees.
ASSEMBLY FLOOR: 68-0, 4/16/26
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Boerner, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO VOTE RECORDED: Arambula, Berman, Bonta, Dixon, Flora, Harabedian, Hart, Hoover, Irwin, Papan, Celeste Rodriguez, Schiavo
Prepared by: Jen Flory / HEALTH / (916) 651-4111
8/24/26 13:48:55
**** END ****
SENATE RULES COMMITTEE Office of Senate Floor Analyses (916) 651-4171 | AB 2571 |
THIRD READING
Bill No: AB 2571
Author: Flora (R)
Amended: 6/8/26 in Senate
Vote: 21
SENATE HEALTH COMMITTEE: 9-0, 6/3/26
AYES: Weber Pierson, Valladares, Caballero, Durazo, Gonzalez, Grove, Menjivar, Padilla, Pérez
NO VOTE RECORDED: Rubio, Smallwood-Cuevas
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/13/26
AYES: Cervantes, Seyarto, Cabaldon, Dahle, Grayson, Richardson, Wahab
ASSEMBLY FLOOR: 68-0, 4/16/26 (Consent) - See last page for vote
SUBJECT: Reimbursement for pharmacist services
SOURCE: California Society of Health-System Pharmacists
DIGEST:
This bill requires a health plan or health insurer to pay or reimburse the cost of covered services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer. Requires the Department of Health Care Services to reimburse enrolled Medi-Cal pharmacists for pharmacy services; reimburse enrolled advanced practice pharmacists for medication therapy management services, reimburse advanced practice pharmacists at the same rate as physicians, and submit a state plan amendment to recognize pharmacists as providers at federally qualified health centers and rural health clinics.
ANALYSIS:
Existing law:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Service Plan Act of 1975 (Knox-Keene Act); California Department of Insurance (CDI) to regulate health and other insurance; and, the Department of Health Care Services (DHCS) to administer the Medi-Cal program. [Health and Safety Code [HSC] §1340, et seq., Insurance Code [INS] §106, et seq., and Welfare and Institutions Code [WIC] §14000, et seq.]
- Requires a health plan or health insurer covering hospital, medical, or surgical expenses, that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the health plan or health insurance has an out-of-network pharmacy benefit. [HSC §1368.5 and INS §10125.1]
- Requires payment or reimbursement described in 2) above to be made for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
- The service performed is within the lawful scope of practice of the pharmacist;
- The coverage otherwise provides reimbursement for identical services performed by other licensed health care providers; and,
- This does not require the plan or insurer to pay a claim to more than one provider for duplicate service or limit physician reimbursement. [HSC §1368.5 and INS §10125.1]
- Establishes pharmacist services as a Medi-Cal benefit, subject to federal approval, DHCS protocols, and utilization controls. [WIC §14132.968]
- Sets the reimbursement rate for pharmacist services, except for medication therapy management, at 85% of the fee schedule for physician services. [WIC §14132.968]
- Requires DHCS, subject to an annual appropriation for this express purpose, to implement a medication therapy management reimbursement methodology for covered pharmacist services related to the dispensing of qualified specialty drugs by an eligible pharmacy contracted with DHCS. Defines “medication therapy management” as a distinct service or group of services, as determined by DHCS, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes. [WIC §14132.969]
- Defines, for purposes of reimbursement to federally qualified health centers and rural health clinics, a “visit” as a face-to-face encounter between a health center or clinic patient and a physician, physician assistant, nurse practitioner, certified nurse-midwife, clinical psychologist, licensed clinical social worker, licensed professional clinical counselor, or a visiting nurse. A visit also includes a face-to-face encounter between a health center or clinic patient and a comprehensive perinatal practitioner providing comprehensive perinatal services, a four-hour day of attendance at an adult day health care center, and any other provider identified in the state plan’s definition of a federally qualified health center or rural health clinic visit. [WIC §14132.100]
- Establishes licensure for an advanced practice pharmacist, and requires the person to meet all of the following:
- Hold an active license to practice pharmacy issued that is in good standing; and,
- Satisfy any two of the following criteria:
- Earn certification in a relevant area of practice, including, but not limited to, ambulatory care, critical care, geriatric pharmacy, nuclear pharmacy, nutrition support pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, or psychiatric pharmacy, from an organization recognized by the Accreditation Council for Pharmacy Education or another entity recognized by California Board of Pharmacy;
- Complete a postgraduate residency through an accredited postgraduate institution where at least 50% of the experience includes the provision of direct patient care services with interdisciplinary teams; or,
- Have provided clinical services to patients for at least one year under a collaborative practice agreement or protocol with a physician, advanced practice pharmacist, pharmacist practicing collaborative drug therapy management, or health system. [Business and Professions Code (BPC) §4210]
- Allows a pharmacist recognized by the Board of Pharmacy as an advanced practice pharmacist to do all of the following:
- Perform patient assessments;
- Order and interpret drug therapy-related tests;
- Refer patients to other health care providers;
- Participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers; and,
- Initiate, adjust, or discontinue drug therapy, as specified. [BPC §4052.6]
This bill:
- Requires a health plan or health insurer, except for Medi-Cal plans, to pay or reimburse the cost of services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer, and the service is similar, rather than identical, to those performed by other licensed providers. Specifies that pharmacists providing services at federally qualified health centers or rural health clinics are included as pharmacists.
- Requires DHCS to reimburse advanced practice pharmacist services no less than 85% of the fee schedule for physician services under the Medi-Cal program, including for medication therapy management.
- Authorizes pharmacists to submit for Medi-Cal reimbursement for pharmacist services, rather than just a pharmacy, so long as the pharmacist is an enrolled Medi-Cal provider before providing the service.
- Authorizes enrolled advanced practice pharmacists, in addition to enrolled Medi-Cal pharmacies, to submit for Medi-Cal reimbursement for medication therapy management services, including those operating at federally qualified health centers or rural health clinics.
- Requires DHCS to seek federal approval of a state plan amendment to recognize pharmacists as providers at federally qualified health centers and rural health clinics for Medi-Cal reimbursement.
Background
According to the author of this bill:
This bill strengthens pharmacists’ role as healthcare providers through expanded reimbursement and integration into Medi-Cal and insurance frameworks. It strengthens the case for pharmacies to operate in underserved areas and improves equitable access to basic and preventive care. Expanding reimbursement options also enables pharmacists to provide services more effectively, reducing hospitalizations, mitigating chronic conditions and improving overall health. This bill makes it viable for pharmacists to continue their work in areas where a brick-and-mortar pharmacy does not exist and promotes equity and continuity of care.
Medication therapy management. The Medi-Cal program has a specific medication therapy management program for Medi-Cal recipients with complex medication therapies, high prescription costs or other risk factors that may result in poor medication adherence as defined by DHCS. Medi-Cal recipients are eligible for these services if they are not in an inpatient or institutional setting, not eligible for Medicare Part D (this service is already covered by Part D plans), are prescribed and are currently taking a qualified specialty drug for a specified chronic or complex disease, are taking five or more chronic medications or have a single medication that Medi-Cal pays more than $75,000 for, are prescribed, and meet one of nine specified categories indicating risks of treatment failure. Eligible recipients must agree to participate in medication therapy management and can opt out at any time. Recipients eligible for the services can have six one-hour encounters per year without prior authorization; more with medical justification.
While state statute and regulations do not specifically refer to medication therapy management in the commercial market for health plans and insurance, coverage of such a service is not precluded. However, state law currently limits coverage of services provided by a pharmacist to those services provided in a pharmacy. This bill would allow pharmacists enrolled with the plan or insurer, rather than just pharmacies, to bill for the benefit, thus enabling pharmacists working in patient care settings to bill. If the plan or insurer covers the service, they must reimburse the contracted pharmacist billing for the service.
Pharmacist health services. In addition to the medication management services, pharmacists in California are authorized to initiate and furnish specified health services. SB 493 (Hernandez, Chapter 469, Statutes of 2013) expanded the scope of practice of a pharmacist to permit pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, as specified, and authorized pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions. According to the Board of Pharmacy, under existing California law and regulation, qualified pharmacists are authorized to initiate and furnish the health services listed below to patients without a prescription:
- Self-administered hormonal contraception;
- Emergency contraception;
- Vaccinations;
- Travel medications;
- Nicotine replacement therapy;
- Naloxone; and,
- HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP).
Advanced practice pharmacists. SB 493 also created in statute a recognized category known as an advanced practice pharmacist (or “advanced pharmacist practitioner”). An advanced practice pharmacist must hold an active license to practice pharmacy in good standing and have additional certification, postgraduate study, and experience in providing clinical services under a collaborative practice agreement. A pharmacist recognized by the Board as an advanced practice pharmacist is authorized to perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy pursuant to a specific written order or authorization made by the individual’s treating prescriber, and in accordance with the policies, procedures or protocols of the health care facility, home health agency, licensed clinic, health plan or physician. According to the Board of Pharmacy, there are currently 1,433 advanced practice pharmacists. The Medi-Cal provisions of this bill would limit pharmacist reimbursement for medication therapy management services to advanced practice pharmacists when billing outside of a pharmacy setting.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: Yes
According to the Senate Appropriations Committee:
- Unknown ongoing costs, potentially hundreds of thousands, for DHCS for state administration and unknown cost pressures in the Medi-Cal program related to reimbursements for pharmacist services (General Fund and federal funds).
- DMHC anticipates minor and absorbable costs for state administration.
- CDI estimates costs of $3,000 in 2026-27 and $16,000 in 2027-28 for state administration (Insurance Fund).
SUPPORT: (Verified 8/13/2026)
California Society of Health-System Pharmacists (source)
America’s Physician Groups
American Society of Health-System Pharmacists
California Academy of Family Physicians
California Access Coalition
California Medical Association
California Pharmacists Association
California Primary Care Association Advocates
California State Board of Pharmacy
City and County of San Francisco
County of Kern, Supervisor Chris Parlier
Keck Medicine of the University of Southern California
National Hispanic Pharmacists Association
Stanford Medicine Children's Health
TrueCare
OPPOSITION: (Verified 8/13/2026)
None received
ARGUMENTS IN SUPPORT: The source of this bill, the California Society of Health-System Pharmacists, writes that under current law, pharmacists’ medication therapy management services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy. This outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures have created pharmacy deserts in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. This bill will enable pharmacists embedded in clinics, federally qualified health centers, rural health centers, hospitals, and telehealth programs to provide comprehensive medication reviews, titrate therapies under collaborative practice agreements, and manage chronic conditions such as diabetes, hypertension, and asthma. They state that medication therapy services have consistently demonstrated improvements in medication adherence, reductions in avoidable hospitalizations and emergency department visits, and overall decreases in health care spending, particularly for high-need Medi-Cal enrollees.
ASSEMBLY FLOOR: 68-0, 4/16/26
AYES: Addis, Aguiar-Curry, Ahrens, Alanis, Alvarez, Ávila Farías, Bains, Bauer-Kahan, Bennett, Boerner, Bryan, Calderon, Caloza, Carrillo, Castillo, Chen, Connolly, Davies, DeMaio, Elhawary, Ellis, Fong, Gabriel, Gallagher, Garcia, Gipson, Jeff Gonzalez, Mark González, Hadwick, Haney, Jackson, Johnson, Kalra, Krell, Lackey, Lee, Lowenthal, Macedo, McKinnor, Muratsuchi, Nguyen, Ortega, Pacheco, Patel, Patterson, Pellerin, Petrie-Norris, Quirk-Silva, Ramos, Ransom, Michelle Rodriguez, Rogers, Blanca Rubio, Sanchez, Schultz, Sharp-Collins, Solache, Soria, Stefani, Ta, Tangipa, Valencia, Wallis, Ward, Wicks, Wilson, Zbur, Rivas
NO VOTE RECORDED: Arambula, Berman, Bonta, Dixon, Flora, Harabedian, Hart, Hoover, Irwin, Papan, Celeste Rodriguez, Schiavo
Prepared by: Jen Flory / HEALTH / (916) 651-4111
8/14/26 10:32:35
**** END ****
SENATE COMMITTEE ON
Senator Sabrina Cervantes, Chair
2025 - 2026 Regular Session
AB 2571 (Flora) - Reimbursement for pharmacist services
Version: | Policy Vote: |
Urgency: | Mandate: |
Hearing Date: | Consultant: |
Bill Summary:
AB 2571 would make changes to reimbursement policies for pharmacist services.
Fiscal Impact:
- Unknown ongoing costs, potentially hundreds of thousands, for the Department of Health Care Services (DHCS) for state administration and unknown cost pressures in the Medi-Cal program related to reimbursements for pharmacist services (General Fund and federal funds).
- The Department of Managed Health Care (DMHC) anticipates minor and absorbable costs for state administration.
- The California Department of Insurance estimates costs of $3,000 in 2026-27 and $16,000 in 2027-28 for state administration (Insurance Fund).
Background:
Pharmacist Services. Under existing California law and regulations, qualified pharmacists are authorized to initiate and furnish the health services listed below to patients without a prescription:
- Self-administered hormonal contraception;
- Emergency contraception;
- Vaccinations;
- Travel medications;
- Nicotine replacement therapy;
- Naloxone; and,
- HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP).
Current law also authorizes the category of an “advanced practice pharmacist.” An advanced practice pharmacist recognized by the Board of Pharmacy is authorized to perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy pursuant to a specific written order or authorization made by the individual’s treating prescriber, and in accordance with the policies, procedures or protocols of the health care facility, home health agency, licensed clinic, health plan or physician.
Health Plan and Insurer Reimbursements for Pharmacist Services. Current law requires health plans and insurers that offer coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the health plan/insurer has an out-of-network pharmacy benefit. Payment or reimbursement may be made for a service performed by a duly licensed pharmacist only when the following conditions are met:
- The service performed is within the lawful scope of practice of the pharmacist.
- The coverage otherwise provides reimbursement for identical services performed by other licensed health care providers.
Medi-Cal Reimbursements for Pharmacist Services. Current law establishes pharmacist services as a benefit under the Medi-Cal program, subject to approval by the federal government. Current law requires DHCS to establish a fee schedule for specified pharmacist services. The rate of reimbursement for pharmacist services must be at 85 percent of the fee schedule for physician services under the Medi-Cal program, except for “medication therapy management” (MTM) pharmacist services. The Medi-Cal program has a specific MTM program for Medi-Cal recipients with complex medication therapies, high prescription costs or other risk factors that may result in poor medication adherence. Reimbursements for MTM pharmacist services are only available to a Medi-Cal enrolled pharmacy that enters into an MTM pharmacist services contract with DHCS. Current law requires DHCS to establish and maintain rates of reimbursement for covered MTM pharmacist services.
Proposed Law:
Specific provisions of the bill would:
- Require health plans and insurers that offer coverage for pharmacist services to pay or reimburse the cost of the service performed by a pharmacist enrolled as a provider with the health plan/insurer; and provide that “pharmacist” includes a pharmacist providing services at a federally qualified health center or a rural health clinic.
- Authorize pharmacists to submit for Medi-Cal reimbursement for pharmacist services, so long as the pharmacist is an enrolled Medi-Cal provider before providing the service.
- Require DHCS to seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers and rural health clinics for reimbursement purposes under the Medi-Cal program.
- Authorize Medi-Cal MTM pharmacist services reimbursements to eligible advanced practice pharmacists, including those operating at federally qualified health centers or rural health clinics.
- Require the rate of Medi-Cal reimbursement for advanced practice pharmacist services to be no less than 85 percent of the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services.
Related Legislation:
AB 2565 (Wallis) would require DHCS to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services. The bill is scheduled to be heard June 15, 2026 in this committee.
-- END --
SENATE COMMITTEE ON HEALTH
Senator Akilah Weber Pierson, Chair
BILL NO: AB 2571
AUTHOR: | Flora | ||
VERSION: | May 20, 2026 | ||
HEARING DATE: | June 3, 2026 | ||
CONSULTANT: | Jen Flory | ||
SUBJECT: Reimbursement for pharmacist services
SUMMARY:
Requires a health plan or health insurer to pay or reimburse the cost of covered services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer. Requires the Department of Health Care Services to reimburse enrolled Medi-Cal pharmacists for pharmacy services; reimburse enrolled advanced practice pharmacists for medication therapy management services, reimburse advanced practice pharmacists at the same rate as physicians, and submit a state plan amendment to recognize pharmacists as providers at federally qualified health centers and rural health clinics.
Existing law:
- Establishes the Department of Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Service Plan Act of 1975 (Knox-Keene Act); California Department of Insurance (CDI) to regulate health and other insurance; and, the Department of Health Care Services (DHCS) to administer the Medi-Cal program. [HSC §1340, et seq., INS §106, et seq., and WIC §14000, et seq.]
- Requires a health plan or health insurer covering hospital, medical, or surgical expenses, that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the health plan or health insurance has an out-of-network pharmacy benefit. [HSC §1368.5 and INS §10125.1]
- Requires payment or reimbursement described in 2) above to be made for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
- The service performed is within the lawful scope of practice of the pharmacist;
- The coverage otherwise provides reimbursement for identical services performed by other licensed health care providers; and,
- This does not require the plan or insurer to pay a claim to more than one provider for duplicate service or limit physician reimbursement. [HSC §1368.5 and INS §10125.1]
- Establishes pharmacist services as a Medi-Cal benefit, subject to federal approval, DHCS protocols, and utilization controls. [WIC §14132.968]
- Sets the reimbursement rate for pharmacist services, except for medication therapy management, at 85% of the fee schedule for physician services. [WIC §14132.968]
- Requires DHCS, subject to an annual appropriation for this express purpose, to implement a medication therapy management reimbursement methodology for covered pharmacist services related to the dispensing of qualified specialty drugs by an eligible pharmacy contracted with DHCS. Defines “medication therapy management” as a distinct service or group of services, as determined by DHCS, that are provided by pharmacists to improve health outcomes of beneficiaries who are at risk of treatment failure due to noncompliance, nonadherence, or other factors found to negatively affect drug therapy outcomes. [WIC §14132.969]
- Defines, for purposes of reimbursement to federally qualified health centers and rural health clinics, a “visit” as a face-to-face encounter between a health center or clinic patient and a physician, physician assistant, nurse practitioner, certified nurse-midwife, clinical psychologist, licensed clinical social worker, licensed professional clinical counselor, or a visiting nurse. A visit also includes a face-to-face encounter between a health center or clinic patient and a comprehensive perinatal practitioner providing comprehensive perinatal services, a four-hour day of attendance at an adult day health care center, and any other provider identified in the state plan’s definition of a federally qualified health center or rural health clinic visit. [WIC §14132.100]
- Establishes licensure for an advanced practice pharmacist, and requires the person to meet all of the following:
- Hold an active license to practice pharmacy issued that is in good standing; and,
- Satisfy any two of the following criteria:
- Earn certification in a relevant area of practice, including, but not limited to, ambulatory care, critical care, geriatric pharmacy, nuclear pharmacy, nutrition support pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, or psychiatric pharmacy, from an organization recognized by the Accreditation Council for Pharmacy Education or another entity recognized by California Board of Pharmacy;
- Complete a postgraduate residency through an accredited postgraduate institution where at least 50% of the experience includes the provision of direct patient care services with interdisciplinary teams; or,
- Have provided clinical services to patients for at least one year under a collaborative practice agreement or protocol with a physician, advanced practice pharmacist, pharmacist practicing collaborative drug therapy management, or health system. [BPC §4210]
- Allows a pharmacist recognized by the Board of Pharmacy as an advanced practice pharmacist to do all of the following:
- Perform patient assessments;
- Order and interpret drug therapy-related tests;
- Refer patients to other health care providers;
- Participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers; and,
- Initiate, adjust, or discontinue drug therapy, as specified. [BPC §4052.6]
This bill:
- Requires a health plan or health insurer to pay or reimburse the cost of services performed by a pharmacist if the pharmacist is enrolled as a provider with the health plan or insurer. Specifies that pharmacists providing services at federally qualified health centers or rural health clinics are included as pharmacists.
- Requires payment for covered services that are similar, rather than identical, to those performed by other licensed providers.
- Requires DHCS to reimburse advanced practice pharmacist services the same as the fee schedule for physician services under the Medi-Cal program, including for medication therapy management.
- Authorizes pharmacists to submit for Medi-Cal reimbursement for pharmacist services, rather than just a pharmacy, so long as the pharmacist is an enrolled Medi-Cal provider before providing the service.
- Authorizes enrolled advanced practice pharmacists, in addition to enrolled Medi-Cal pharmacies, to submit for Medi-Cal reimbursement for medication therapy management services, including those operating at federally qualified health centers or rural health clinics.
- Requires DHCS to seek federal approval of a state plan amendment to recognize pharmacists as providers at federally qualified health centers and rural health clinics for Medi-Cal reimbursement.
FISCAL EFFECT:
According to the Assembly Committee on Appropriations, this bill would have the following fiscal effect:
- DHCS estimates the annual cost to be in the low tens of thousands of dollars (General Fund, federal funds).
- CDI estimates costs of $3,000 in fiscal year (FY) 2026-27 and $16,000 in FY 2027-28 to review health insurance policies for compliant language (Insurance Fund).
- DMHC anticipates minor and absorbable costs.
PRIOR VOTES:
Assembly Floor: | 68 - 0 |
Assembly Appropriations Committee: | 14 - 0 |
Assembly Health Committee: | 16 - 0 |
COMMENTS:
- Author’s statement. According to the author, this bill strengthens pharmacists’ role as healthcare providers through expanded reimbursement and integration into Medi-Cal and insurance frameworks. It strengthens the case for pharmacies to operate in underserved areas and improves equitable access to basic and preventive care. Expanding reimbursement options also enables pharmacists to provide services more effectively, reducing hospitalizations, mitigating chronic conditions and improving overall health. This bill makes it viable for pharmacists to continue their work in areas where a brick-and-mortar pharmacy does not exist and promotes equity and continuity of care.
- Medication therapy management. The Medi-Cal program has a specific medication therapy management program for Medi-Cal recipients with complex medication therapies, high prescription costs or other risk factors that may result in poor medication adherence as defined by DHCS. According to the DHCS provider manual, DHCS will contract for medication therapy management with any outpatient pharmacy that will sign a contract to meet a list of performance obligations. Medi-Cal recipients are eligible for these services if they are not in an inpatient or institutional setting, not eligible for Medicare Part D (this service is already covered by Part D plans), are prescribed and are currently taking a qualified specialty drug for a specified chronic or complex disease (e.g. diabetes, asthma, hypertension, HIV/AIDS, cancer, severe mental health disorders, autoimmune disorders, etc.), are taking five or more chronic medications or have a single medication that Medi-Cal pays more than $75,000 for, are prescribed, and meet one of nine specified categories indicating risks of treatment failure (e.g. demonstrated nonadherence, laboratory values that could be improved by medication adherence, use of high-risk medications). Eligible recipients must agree to participate in the medication therapy management and can opt out at any time. Recipients eligible for the services can have six one-hour encounters per year without prior authorization; more with medical justification.
While state statute and regulations do not specifically refer to medication therapy management in the commercial market for health plans and insurance, coverage of such a service is not precluded. However, state law currently limits coverage of services provided by a pharmacist to those services provided in a pharmacy. This bill would allow pharmacists enrolled with the plan or insurer, rather than just pharmacies, to bill for the benefit, thus enabling pharmacists working in patient care settings to bill. If the plan or insurer covers the service, they must reimburse the contracted pharmacist billing for the service.
- Pharmacist health services. In addition to the medication management services, pharmacists in California are authorized to initiate and furnish specified health services. SB 493 (Hernandez, Chapter 469, Statutes of 2013) expanded the scope of practice of a pharmacist to permit pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, as specified, and authorized pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions. According to the Board of Pharmacy, under existing California law and regulation, qualified pharmacists are authorized to initiate and furnish the health services listed below to patients without a prescription:
- Self-administered hormonal contraception;
- Emergency contraception;
- Vaccinations;
- Travel medications;
- Nicotine replacement therapy;
- Naloxone; and,
- HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP).
- Advanced practice pharmacists. SB 493 also created in statute a recognized category known as an advanced practice pharmacist (or “advanced pharmacist practitioner”). An advanced practice pharmacist must hold an active license to practice pharmacy in good standing and have additional certification, postgraduate study, and experience in providing clinical services under a collaborative practice agreement. A pharmacist recognized by the Board as an advanced practice pharmacist is authorized to perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy pursuant to a specific written order or authorization made by the individual’s treating prescriber, and in accordance with the policies, procedures or protocols of the health care facility, home health agency, licensed clinic, health plan or physician. According to the Board of Pharmacy, there are currently 1,433 advanced practice pharmacists. The Medi-Cal provisions of this bill would limit pharmacist reimbursement for medication therapy management services to advanced practice pharmacists when billing outside of a pharmacy setting.
- Related legislation. AB 2565 (Wallis) would require DHCS to issue guidance clarifying Medi-Cal managed care plan obligations to cover pharmacist services and take appropriate corrective action for failure to comply with existing law related to Medi-Cal coverage of pharmacist services or the issued guidance. AB 2565 is set for hearing on June 3, 2026 in this Committee.
- Prior legislation. AB 1366 (Flora of 2025) was substantially similar to this bill. AB 1366 was held on the Assembly Appropriations suspense file.
AB 317 (Weber, Chapter 322, Statutes of 2023) requires, instead of permits, a health plan or health insurance to pay or reimburse for the cost of pharmacist services provided at an in-network pharmacy or an out-of-network pharmacy if the health plan or insurer has an out-of-network pharmacy benefit.
AB 1114 (Eggman, Chapter 602, Statutes of 2016) requires pharmacist services to be a benefit under the Medi-Cal program, establishes a list of covered pharmacist services that may be provided to a Medi-Cal beneficiary, and requires the DHCS to establish a fee schedule for the list of pharmacist services to be 85% of the fee schedule for physician services under the Medi-Cal program.
SB 493 (Hernandez, Chapter 469, Statutes of 2013) expands the scope of practice of a pharmacist to recognize an advanced practice pharmacist, permits pharmacists to furnish certain hormonal contraceptives, nicotine replacement products, and prescription medications for travel, and authorizes pharmacists to independently initiate and administer certain vaccines and treatments for severe allergic reactions.
- Support. Sponsor, the California Society of Health-System Pharmacists, writes that under current law, pharmacists’ medication therapy management services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy. This outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures have created pharmacy deserts in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. This bill will enable pharmacists embedded in clinics, federally qualified health centers, rural health centers, hospitals, and telehealth programs to provide comprehensive medication reviews, titrate therapies under collaborative practice agreements, and manage chronic conditions such as diabetes, hypertension, and asthma. They state that medication therapy services have consistently demonstrated improvements in medication adherence, reductions in avoidable hospitalizations and emergency department visits, and overall decreases in health care spending, particularly for high-need Medi-Cal enrollees.
- Amendments. Section 1 should contain an exception for Medi-Cal plans given the requirement that medication therapy management services be reimbursable only to a pharmacy or an eligible advanced practice pharmacist in Section 4 that contradicts the broader language of Section 1. The committee and author have agreed to the following amendment to add to the end of Section 1:
(e) This section does not apply to a Medi-Cal managed care plan that contracts with the State Department of Health Care Services pursuant to Chapter 7 (commencing with Section 14000) and Chapter 8 (commencing with Section 14200) of Part 3 of Division 9 of the Welfare and Institutions Code.
In addition, the committee and author have agreed to the following amendment in Section 4 to address cost or parity concerns regarding the Medi-Cal rate for advanced practice pharmacists, while at the same time giving Medi-Cal plans the flexibility needed to contract with advanced practice pharmacists.
(a)(4) The rate of reimbursement for advanced practice pharmacist services shall be the same as no less than 85% of the fee schedule for physician services under the Medi-Cal program, including MTM pharmacist services as described in Section 14132.969.
SUPPORT AND OPPOSITION:
Support: California Society of Health-System Pharmacists (sponsor)
American Society of Health-System Pharmacists
California Academy of Family Physicians
California Primary Care Association Advocates
California State Board of Pharmacy
Stanford Medicine Children's Health
TrueCare
Oppose: None received.
-- END --
Date of Hearing: April 8, 2026
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Buffy Wicks, Chair
ABPCA Bill Id:AB 2571
Author:(Flora) – As Introduced Ver:February 20, 2026
Policy Committee: | Health | Vote: | 16 - 0 |
|
| ||
|
|
Urgency: No State Mandated Local Program: Yes Reimbursable: No
SUMMARY:
This bill requires the Medi-Cal program, a health care service plan (health plan), and a health insurer reimburse an advanced practice pharmacist (APP) for medication therapy management (MTM) services.
Specifically, this bill:
- Requires a health plan or health insurer pay or reimburse the cost of services performed by an APP if the APP is enrolled as a provider with the health plan or insurer.
- Requires the Medi-Cal program reimburse APP services, including MTM services, at the same fee schedule as for physician services.
- Requires the Department of Health Care Services (DHCS) seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers (FQHCs) for reimbursement under the Medi-Cal program.
- Specifies DHCS, in implementing an MTM reimbursement methodology for covered pharmacist services related to the use of qualified specialty drugs, must ensure Medi-Cal payments are made only to eligible APPs for MTM pharmacist services.
FISCAL EFFECT:
- DHCS estimates the annual cost to be in the low tens of thousands of dollars (General Fund, federal funds).
- The Department of Insurance estimates costs of $3,000 in fiscal year (FY) 2026-27 and $16,000 in FY 2027-28 to review health insurance policies for compliant language (Insurance Fund).
- The Department of Managed Health Care anticipates minor and absorbable costs.
COMMENTS:
- Purpose. This bill is sponsored by the California Society of Health-System Pharmacists. According to the author:
[This bill] strengthens pharmacists’ role as healthcare providers through expanded reimbursement and integration into Medi-Cal and insurance frameworks. It strengthens the case for pharmacies to operate in underserved areas and improves equitable access to basic and preventive care. Expanding reimbursement options also enables pharmacists to provide services more effectively, reducing hospitalizations, mitigating chronic conditions and improving overall health. [This bill] makes it viable for pharmacists to continue their work in areas where a brick-and-mortar pharmacy does not exist and promotes equity and continuity of care.
- Background. MTM and Pharmacy Closures. MTM services can reduce adverse drug events, improve medication adherence and health outcomes, prevent hospitalizations, and reduce costs. Under existing law, health plans and insurers may reimburse pharmacists for MTM services provided within or affiliated with a pharmacy. However, individual pharmacists, such as those employed in hospitals, FQHCs and other clinics, academic medical centers, and physician practices, are not permitted to bill for these services unless affiliated with a pharmacy. Research indicates one in three pharmacies in the U.S. have closed since 2010, creating pharmacy deserts that limit patient access to prescriptions, as well as pharmacist-provided services such as MTM. Pharmacy closures are expected to continue.
APPs. Existing law authorizes pharmacists to furnish compounded drug products, transmit a valid prescription to another pharmacist, and administer drugs and biologicals pursuant to a prescriber's order. SB 493 (Hernandez), Chapter 469, Statutes of 2013, authorized pharmacists to furnish self-administered hormonal contraceptives, vaccines, nicotine replacement products, and travel medications. SB 493 also authorized the State Board of Pharmacy to recognize APPs who may perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy.
- Related Legislation. AB 1366 (Flora), of the current legislative session, was substantially similar to this bill. AB 1366 was held on this committee’s suspense file.
Analysis Prepared by: Allegra Kim / APPR. / (916) 319-2081
Date of Hearing: March 24, 2026
ASSEMBLY COMMITTEE ON HEALTH
Mia Bonta, Chair
ABPCA Bill Id:AB 2571
Author:(Flora) – As Introduced Ver:February 20, 2026
SUBJECT: Reimbursement for pharmacist services.
SUMMARY: Requires advanced practice pharmacists (APPs) enrolled as providers with a health care service plan (health plan), health insurer, or the Medi-Cal program to be reimbursed for medication therapy management (MTM) services. Specifically, this bill:
- Requires a health plan or health insurer to pay or reimburse the cost of services performed by an APP if the APP is enrolled as a provider with the plan or insurer.
- Requires the Medi-Cal program to reimburse APP services, including MTM services, at the same fee schedule for physician services.
- Requires the Department of Health Care Services (DHCS) to implement an MTM reimbursement methodology to ensure that Medi-Cal payments are made to eligible APPs, in addition to pharmacies, for MTM pharmacist services.
- Requires DHCS to seek federal approval of a state plan amendment to recognize pharmacists as health care providers at federally qualified health centers (FQHCs) for reimbursement purposes under the Medi-Cal program.
EXISTING LAW:
- Establishes the Department Managed Health Care (DMHC) to regulate health plans under the Knox-Keene Health Care Service Plan Act of 1975 and California Department of Insurance (CDI) to regulate health insurers. [Health and Safety Code (HSC) § 1340, et seq. and Insurance Code (INS) § 106, et seq.]
- Requires a health plan or insurer, that offers coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of the service performed by a pharmacist at an in-network pharmacy or a pharmacist at an out-of-network pharmacy if the health care service plan has an out-of-network pharmacy benefit. Authorizes payment or reimbursement for a service performed by a duly licensed pharmacist only when all of the following conditions are met:
- The service performed is within the lawful scope of practice of the pharmacist; and,
- The coverage otherwise provides reimbursement for identical services performed by other licensed health care providers. [HSC § 1368.5 and INS § 10125.1]
- Establishes the Medi-Cal Program, administered by DHCS, to provide comprehensive health benefits to low-income individuals who meet specified eligibility criteria. [Welfare and Institutions Code (WIC) § 14000 et seq.]
- Establishes pharmacist services as a benefit under the Medi-Cal program, subject to federal approval. Sets a rate of reimbursement for pharmacist services as 85% of the fee schedule for physician services under the Medi-Cal program. [WIC § 14132.968]
- Requires DHCS to implement an MTM reimbursement methodology for covered pharmacist services related to the dispensing of qualified specialty drugs by an eligible contracting pharmacy. Permits MTM reimbursement only to eligible pharmacies for MTM services. [WIC § 14132.969]
- Defines, for purposes of reimbursement to an FQHC or Rural Health Center (RHC), an FQHC or RHC “visit” as a face-to-face encounter between an FQHC or RHC patient and a physician, physician assistant, nurse practitioner, certified nurse-midwife, clinical psychologist, licensed clinical social worker, licensed professional clinical counselor, or a visiting nurse. A visit also includes a face-to-face encounter between an FQHC or RHC patient and a comprehensive perinatal practitioner providing comprehensive perinatal services, a four-hour day of attendance at an adult day health care center, and any other provider identified in the state plan’s definition of an FQHC or RHC visit. [WIC § 14132.100]
- Establishes licensure for an APP and requires the person to meet all of the following:
- Hold an active license to practice pharmacy that is in good standing; and,
- Satisfy any two of the following criteria:
- Earn certification in a relevant area of practice, including, but not limited to, ambulatory care, critical care, geriatric pharmacy, nuclear pharmacy, nutrition support pharmacy, oncology pharmacy, pediatric pharmacy, pharmacotherapy, or psychiatric pharmacy, from an organization recognized by the Accreditation Council for Pharmacy Education or another entity recognized by Board of Pharmacy (BOP);
- Complete a postgraduate residency through an accredited postgraduate institution where at least 50% of the experience includes the provision of direct patient care services with interdisciplinary teams; or,
- Have provided clinical services to patients for at least one year under a collaborative practice agreement or protocol with a physician, APP, pharmacist practicing collaborative drug therapy management, or health system. [Business and Professions Code (BPC) § 4210]
- Allows a pharmacist recognized by the BOP as an APP to do all of the following:
- Perform patient assessments;
- Order and interpret drug therapy-related tests;
- Refer patients to other health care providers;
- Participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers; and,
- Initiate, adjust, or discontinue drug therapy, as specified. [BPC § 4052.6]
FISCAL EFFECT: Unknown. This bill has not been analyzed by a fiscal committee.
COMMENTS:
- PURPOSE OF THIS BILL. According to the author, MTM is a proven, cost-effective service that improves patient outcomes, reduces healthcare spending, and addresses chronic disease management gaps—particularly in underserved communities. The author states that pharmacists are uniquely qualified medication experts who help patients manage complex drug regimens, identify harmful interactions, and increase adherence to prescribed treatments. The author continues that these services, whether provided in a community pharmacy, clinic, hospital, or via telehealth, directly reduce emergency room visits, hospitalizations, and avoidable complications. The author argues that limiting reimbursement to services performed within a brick-and-mortar pharmacy ignores the evolving realities of healthcare delivery, especially in the face of widespread pharmacy closures and the expansion of mobile and remote care models. The author concludes that paying pharmacists for MTM regardless of location not only aligns with modern healthcare infrastructure but also ensures equitable access to life-saving services for the Medi-Cal patients who need them most.
- BACKGROUND.
- MTM. MTM is a strategy to improve health outcomes and detect and prevent costly medication problems. MTM services aim to improve medication adherence, reduce adverse drug events, prevent hospitalizations, and produce measurable cost savings. Numerous studies provided by the author’s office offer evidence that MTM programs can reduce total healthcare spending by optimizing therapeutic outcomes, eliminating unnecessary or duplicative medication use, and improving management of chronic conditions such as diabetes, hypertension, and asthma. Current law authorizes pharmacists to be reimbursed for MTM services; however, those services must be provided within or affiliated with a pharmacy. Individual pharmacists, such as those employed in hospitals, FQHCs, rural health clinics, mobile clinics, academic medical centers, and physician practices, are not permitted to bill for these services without affiliation at a pharmacy. This discrepancy in reimbursement structure is impactful as brick-and-mortar pharmacies are rapidly declining across the state. According to research published by the UC Berkeley School of Public Health and the University of Southern California, 1 in 3 pharmacies have closed since 2010 and thousands more closures are expected in the coming years. These closures have created pharmacy deserts that not only impact patient access to prescriptions, but also pharmacist-provided services such as MTM due to reimbursement limitations.
- APPs. Existing law authorizes pharmacists to furnish compounded drug products, transmit a valid prescription to another pharmacist, and administer drugs and biologicals pursuant to a prescriber's order. SB 493 (Hernandez), Chapter 469, Statutes of 2013, expands the scope of pharmacists to authorize them to furnish self-administered hormonal contraceptives, vaccines, nicotine replacement products, and travel medications. Additionally, SB 493 authorizes the BOP to recognize APPs who can perform patient assessments, order and interpret drug therapy-related tests, refer patients to other health care providers, participate in the evaluation and management of diseases and health conditions in collaboration with other health care providers, and initiate, adjust, or discontinue drug therapy.
- Reimbursement to Pharmacists Would be New for Medi-Cal. Medi-Cal covers pharmacist services; however, these services are reimbursed to contracting pharmacies, not directly to pharmacists. For pharmacists to receive reimbursement directly, DHCS would likely have to create an enrollment pathway, and pharmacists would have to newly enroll as billing providers. Pharmacists are also similarly not recognized as “reimbursable” providers within an FQHC or RHC if services are provided outside of a pharmacy [see 6) above of Existing Law for the list of recognized providers within an FQHC or RHC setting]. Enrolling and reimbursing advance practice pharmacists directly could improve access to services provided by these pharmacists, such as MTM, and could increase the flexibility of how pharmacists may be used as part of care teams within health care systems.
- SUPPORT. The California Society of Health-System Pharmacists (CSHP), sponsors of this bill, state that under current law, pharmacists’ MTM services can generally be reimbursed only when delivered within or affiliated with a brick-and-mortar pharmacy, despite the fact that pharmacists increasingly practice in clinics, hospitals, physician group practices, mobile health units, and other community-based settings. CSHP continues that this outdated restriction fails to reflect modern, team-based care models and has become especially harmful as pharmacy closures accelerate in low-income and rural communities, eliminating primary access points for many Medi-Cal beneficiaries. CSHP argues that this bill addresses this gap by allowing Medi-Cal and health plans to reimburse individual pharmacists enrolled as providers for MTM services regardless of whether those services are delivered in a traditional pharmacy or in another clinical setting. CSHP concludes that by recognizing pharmacists as reimbursable providers in a wider range of settings, this bill will expand access to preventive and chronic care services, improve continuity of care, and advance health equity for patients living in “pharmacy deserts” and other medically underserved communities.
- SUPPORT IF AMENDED. The California Pharmacists Association (CPA) supports this bill if amended, acknowledging that it is an important step toward improving access to care, enhancing MTM, and supporting the overall efficiency of the health care system. CPA requests that the bill be amended to apply to all pharmacists, not just APPs, stating that all pharmacists are trained and authorized to provide the services contemplated in this bill. CPA also request that the bill be amended to remove the 100% physician fee schedule reimbursement requirement, which they don’t believe is feasible given the state’s current fiscal constraints. Lastly, CPA requests that the bill be amended to explicitly include FQHCs and pharmacies. With these amendments, CPA believes this bill would more effectively expand access to pharmacist-provided care, support a broader segment of the pharmacy workforce, and do so in a fiscally responsible manner.
- PREVIOUS LEGISLATION.
- AB 1366 (Flora) of 2025 was substantially similar to this bill. AB 1366 was held on the Assembly Appropriations Committee suspense file.
- AB 317 (Weber), Chapter 322, Statutes of 2023, requires, instead of permits, a health plan and specified disability insurers that offer coverage for a service that is within the scope of practice of a duly licensed pharmacist to pay or reimburse the cost of services performed by a pharmacist at an in-network pharmacy or by a pharmacist at an out-of-network pharmacy if the health plan or insurer has an out-of-network pharmacy benefit.
- AB 1114 (Eggman), Chapter 602, Statutes of 2016, adds to the schedule of Medi-Cal benefits pharmacist services, as specified, subject to DHCS protocols and utilization controls. Requires the rate of reimbursement for pharmacist services to be at 85% of the fee schedule for physician services under the Medi-Cal program and requires DHCS to establish a fee schedule. Authorizes DHCS to implement these provisions by means of all-county letters, plan letters, plan or provider bulletins, or similar instructions, without taking regulatory action, until regulations are adopted, and requires DHCS to adopt those regulations by July 1, 2021. Requires these provisions to be implemented only to the extent that federal financial participation is available and the necessary federal approvals are obtained.
- SB 493 (Hernandez), Chapter 469, Statutes of 2013 authorizes a pharmacist to administer drugs and biological products that have been ordered by a prescriber. Authorizes pharmacists to perform other functions, including, among other things, to furnish self-administered hormonal contraceptives, nicotine replacement products, and prescription medications not requiring a diagnosis that are recommended for international travelers, as specified. Authorizes pharmacists to order and interpret tests for the purpose of monitoring and managing the efficacy and toxicity of drug therapies, and to independently initiate and administer routine vaccinations, as specified. Establishes BOP recognition for an APP, as defined, and specifies the criteria for that recognition, and specifies additional functions that may be performed by an APP, including, among other things, performing patient assessments, and certain other functions, as specified. Authorizes BOP, by regulation, to set the fee for the issuance and renewal of APP recognition at the reasonable cost of regulating APPs pursuant to these provisions, not to exceed $300.
REGISTERED SUPPORT / OPPOSITION:
Support
California Society of Health-System Pharmacists (sponsor)
California Academy of Family Physicians
Stanford Medicine Children's Health
Opposition
None on file
Analysis Prepared by: Riana King / HEALTH / (916) 319-2097
Discussed in Hearing
View Older HearingsBill Author
Bill Co-Author(s):